Esaprazole

An inhibitor of HIV-1 protease (EC50 = 2.6 nM) commonly used in vivo in combination therapy for HIV-1 infection.

ERK Inhibitor II, Negative Control is a cell-permeable pyrazolopyridazinol that serves as a (-) control for ERK Inhibitor II. ERK Inhibitor II, Negative Control has been shown to exhibit little activity towards ERK1 and ERK2 or in blocking

InformationImportazole is a small molecule inhibitor of thetransport receptor importin-β (Karyopherin beta)specifically blocking importin-β-mediated nuclear import. Importazole inducesapoptosisand inhibits tumor growth.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.